Skip to content

Simplified Management of Obstructive Sleep Apnea in General Practice

A randomised controlled trial to evaluate a simplified management strategy for moderate-to-severe obstructive sleep apnea comparing improvements in daytime sleepiness in patients managed in primary care (general practitioner assisted by a sleep specialist nurse) versus usual care in a sleep specialist centre

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12608000514303
Acronym
SMOSA2
Enrollment
250
Registered
2008-10-02
Start date
2008-11-03
Completion date
2010-09-20
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

This study will compare health outcomes and costs for patients diagnosed with moderate to severe obstructive sleep apnea managed by either their general practitioner assisted by a sleep-trained nurse in the community or by a sleep physician in a hospital outpatient setting.

Interventions

General practice-based management for a total of 6 months. Patients will have an auto-continuous positive airway pressure (CPAP) titration study at home over 3 nights to determine their CPAP treatment pressure. CPAP therapy will be worn by patients at night for the 6 month duration of the study and followed up by a sleep nurse based in the community at 1, 3 and 6 months and their general practitioner at 3 and 6 months. Each follow-up visit with the nurse will be of 30 minutes duration, and 15-20

General practice-based management for a total of 6 months. Patients will have an auto-continuous positive airway pressure (CPAP) titration study at home over 3 nights to determine their CPAP treatment pressure. CPAP therapy will be worn by patients at night for the 6 month duration of the study and followed up by a sleep nurse based in the community at 1, 3 and 6 months and their general practitioner at 3 and 6 months. Each follow-up visit with the nurse will be of 30 minutes duration, and 15-20 minutes for general practitioner review.

Sponsors

National Health and Medical Research Council
Lead SponsorGovernment body

Study design

Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Treatment
Masking
Open (masking not used)

Eligibility

Sex/Gender
All
Age
25 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

Moderate-to-severe obstructive sleep apnea (OSA) - positive on OSA50 screening questionnaire; Epworth sleepiness scale (ESS)>=8 or poorly-controlled hypertension despite 2 or more antihypertensive agents; ApneaLink 3% oxygen desturation index (ODI)>=16

Exclusion criteria

Body mass index (BMI)>50 Neuromuscular disease Significant psychiatric disease which would affect patient's ability to comply with study protocol Cognitive disability that would prevent self management of CPAP Recent hospitalisation for myocardial infarction (MI), unstable angina, cardiac failure, cerebrovascular accident (CVA) or transient ischemic attack (TIA) in past 3 months, and/or New York Heart Association (NYHA) Class 3 or 4 Moderate-to-severe respiratory disease (documented hypoxia or awake oxygen saturation <92%)

Outcome results

None listed

Source: ANZCTR · Data processed: Mar 24, 2026